Send the following on WhatsApp
Continue to Chathttps://it.marketscreener.com/quotazioni/azione/ANNEXIN-PHARMACEUTICALS-A-39436694/attualita/Annexin-Pharmaceuticals-AB-Publ-riceve-l-approvazione-per-iniziare-lo-studio-di-fase-2-negli-Stati-39980600/?utm_source=whatsapp&utm_medium=social&utm_campaign=share